Remove pharma top-20-pharma-companies-2022-revenue
article thumbnail

Market cap growth surges for over half of the top biopharmaceutical companies in 2022

Pharmaceutical Technology

The top 20 companies in the global biopharma industry saw 5.4%* aggregate market capitalization from $3.43 trillion over the past year, according to GlobalData’s Pharma Intelligence Center Companies Database. billion on Dec 31, 2022. trillion to $3.61 Merck & Co. Merck & Co. billion to $281.3

Marketing 195
article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Market cap downturn hits over half of top 20 biopharmaceutical companies in Q1 2023

Pharmaceutical Technology

More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q4 2022 to $3.49 trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% million by 2029.

Marketing 130
article thumbnail

The ins and outs of the life sciences: top hires for October 2022 

pharmaphorum

billion in revenue and 300 FTEs. Clinical-stage biotechnology company, Lineage Cell Therapeutics has announced that Jill Howe will join the company as chief financial officer , effective 14 November. “I am excited to join 1910 Genetics at such a pivotal time for the company,” Genestin said.

article thumbnail

2022 Predictions From the Front-Lines of Pharma Digital Advertising

Pharma Marketing Network

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.

Marketing 105
article thumbnail

Novartis taps smartpatient for app to support wet AMD patients

pharmaphorum

German digital health company smartpatient is adding a new section of its MyTherapy app providing information on wet age-related macular degeneration (AMD), a leading cause of blindness. Wet AMD affects more than 20 million people worldwide, and is the top cause of blindness in people aged over 65. billion from the drug.

article thumbnail

Pfizer says COVID-19 jab could rake in $26bn this year

pharmaphorum

Pfizer expects revenues from its BioNTech-partnered COVID-19 vaccine to reach an eye-watering $26 billion this year, catapulting it to the top of the world’s biggest-selling medicines. . billion – so revenues could come in even higher if that surplus is snapped up. The vaccine made $3.5 1.351 strain. 1.351 strain.